Page 42 - Sohini Das

Car dealer inventories rise despite retail sales of PVs up 4% in May

FADA initiates talks with OEMs on recalibrating production plans

USFDA inspections of Indian sites still below pre-Covid-19 levels

Indian pharma was exposed to an average of 9 per cent of overall global inspections from calendar year 2009 (CY09) to the first quarter (Q1) of 2022-23 (FY23)

Centre bans 14 more fixed dose combination drugs on expert recommendation

One of the key FDCs banned by the Centre includes a commonly used medication - Nimesulide and paracetamol combination - which is used to relieve pain and fever

Indiana Ophthalmics faces CDSCO probe; Pharmexcil may suspend membership

CDSCO starts probe based in complaint by Sri Lanka that eyedrops made by the firm are linked to eye infections in more than 30 people

Mahindra and Mahindra bets on horticulture to drive tractor growth

M&M currently enjoys a 42.2 per cent share of India's tractor market (as of year till date)

Sun Pharma back in black with Rs 1,984-crore net profit in Q4 FY23

The company reported an Ebitda of Rs 2,802 crore, up 19.7 per cent YoY, with a resulting Ebitda margin of 25.6 per cent for Q4 of FY23

Recruiting nurses remain a major hurdle to hospital bed expansion

India has a shortfall of 1.37 mn nurses if we wish to meet the World Health Organisation (WHO) recommendations; and globally there is a need for 13 mn nursing professionals

Pfizer suspends sale of three antibiotics in India over technical issues

Investigating matter with contract manufacturer Astral Steritech, says pharma firm

Medical tech firm Medtronic to invest Rs 3,000 cr for Hyderabad R&D centre

Facility employs 800 people and will take up more 1,500 in the next five years

Health Ministry to put 75 mn with hypertension on standard care by 2025

Around 40,000 primary he­alt­hcare medical officers will be trained on standard treatment workflow for NCDs thro­ugh the Shashakt portal, MoHFW said

AI cannot replace human knowledge: Metropolis Healthcare Promoter & MD

In 2021-22, Covid19 business was almost 20-22% of the revenue for most diagnostic companies. The non-Covid19 business is not going to grow by 22% to make it equal

Be cautious about 'excessive use' of booster Covid doses: Srinath Reddy

Surveillance for new variants of the virus must continue, says distinguished professor at PHFI

Pharma industry seeks graded introduction of trade margin rationalisation

TMR may be applied in phases, with the first one including drugs priced above Rs 100 or so

Under the lens: Regulator moots pre-export govt testing for cough syrup cos

A pharma industry veteran said that the government may consider making glycol testing compulsory for all manufacturers of syrups and solvents

How Covid-19 waves are turning into ripples; dip in latest surge fastest

The fourth time that the 10,000-mark was breached was in April 2023. The latest spike lasted 7 days-the shortest of the four.

Tata Motors reports net profit of Rs 5,408 crore in Q4, revenue surges 35%

The company board has recommended a final dividend of Rs 2 per ordinary share

No plans to sell stake in consumer healthcare biz: Sanofi India MD Hrosz

'Our insulin portfolio today offers best-in-class insulin for better diabetes management'

PV dispatches highest ever in April, grow 13% YoY, shows SIAM data

2W dispatches up 15% YoY, auto body says all segments have posted growth this April, indicating smooth shift to BS VI Phase 2 emission norms

Pricing regulator sets mechanism to fix prices of off-patent drugs

Prices to be capped at 50% of innovator price; to be reviewed after one year

Sanofi consumer brands get a shot in the arm on demerger decision

Demerging the pharma business will help the company focus on niche therapy areas, including bringing its global pipeline to India